Correlation Between LadRx and Sino Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both LadRx and Sino Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LadRx and Sino Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LadRx and Sino Biopharmaceutical Limited, you can compare the effects of market volatilities on LadRx and Sino Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LadRx with a short position of Sino Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of LadRx and Sino Biopharmaceutica.
Diversification Opportunities for LadRx and Sino Biopharmaceutica
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between LadRx and Sino is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding LadRx and Sino Biopharmaceutical Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sino Biopharmaceutical and LadRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LadRx are associated (or correlated) with Sino Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sino Biopharmaceutical has no effect on the direction of LadRx i.e., LadRx and Sino Biopharmaceutica go up and down completely randomly.
Pair Corralation between LadRx and Sino Biopharmaceutica
Assuming the 90 days horizon LadRx is expected to generate 15.38 times more return on investment than Sino Biopharmaceutica. However, LadRx is 15.38 times more volatile than Sino Biopharmaceutical Limited. It trades about 0.07 of its potential returns per unit of risk. Sino Biopharmaceutical Limited is currently generating about 0.01 per unit of risk. If you would invest 1,800 in LadRx on September 2, 2024 and sell it today you would lose (1,604) from holding LadRx or give up 89.11% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 48.38% |
| Values | Daily Returns |
LadRx vs. Sino Biopharmaceutical Limited
Performance |
| Timeline |
| LadRx |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Sino Biopharmaceutical |
LadRx and Sino Biopharmaceutica Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with LadRx and Sino Biopharmaceutica
The main advantage of trading using opposite LadRx and Sino Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LadRx position performs unexpectedly, Sino Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sino Biopharmaceutica will offset losses from the drop in Sino Biopharmaceutica's long position.| LadRx vs. Chart Industries | LadRx vs. Helmerich and Payne | LadRx vs. EMCOR Group | LadRx vs. Newpark Resources |
| Sino Biopharmaceutica vs. Rigel Pharmaceuticals | Sino Biopharmaceutica vs. Geron | Sino Biopharmaceutica vs. Verastem | Sino Biopharmaceutica vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |